Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 7, 2011, Pages 437-443

  Jung, Y E ^a   Jun, T Y ^a   Kim, K S ^a   Bahk, W M ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hyponatremia; Major depressive disorder; Mirtazapine; Selective serotonin reuptake inhibitors (SSRIs); Venlafaxine

Indexed keywords

ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SODIUM; VENLAFAXINE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; HYPONATREMIA; KOREAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CYCLOHEXANOLS; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; HYPONATREMIA; MALE; MIANSERIN; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SODIUM; YOUNG ADULT;

EID: 79960181911     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201500     Document Type: Article

References (39)

1. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000; 58: 19-36. (Pubitemid 30173208)
2. Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999; 60: 4-11.
3. Bourin M. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Hum Psychopharmacol. 2003; 18: 185-190. (Pubitemid 36526943)
4. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 85-102. (Pubitemid 36131110)
5. Kumar S, Berl T. Sodium. Lancet. 1998; 352: 220-228.
6. Spigset O, Hedenmalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drags. Drag Saf. 1995; 12: 209-225.
7. Larsen PR, Kronenberg H, Melmed S, Polonsky K. Williams Textbook of Endocrinology. 10th ed. New York: Elsevier; 2002.
8. Harman JS, Crystal S, Walkup J, Olfson M. Trends in elderly patients' office visits for the treatment of depression according to physician specialty: 1985-1999. J Behav Health Serv Res. 2003; 30: 332-341.
9. Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008; 20: 47-51.
10. Arinson ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002; 36: 1175-1177.
11. Fonzo-Christe C, Vogt N. Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors. Therapie. 2000; 55: 597-604.
12. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999; 47: 211-217. (Pubitemid 29078021)
13. Brownfield MS, Greathouse J, Lorens SA, Armstrong J, Urban JH, Van de Kar LD. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinol. 1988; 47: 277-283
14. Pergola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release. Neuroendocrinol. 1993; 57: 550-558.
15. Roxanas MG. Mirtazapine-induced hyponatremia. Med J Aust. 2003; 179: 453-454.
16. Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr Soc. 2001; 49: 788-792.
17. Herrmann N. Use of SSRIs in the elderly. Can J Clin Pharmacol. 2000; 7: 91-95.
18. Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc. 1996; 44: 404-408.
19. Kelly RE, Robinson H, Beringer TRO. Hyponatremia in an older patient. J Am Geriatr Soc. 1999; 47: 1037-1038.
20. Sharma H, Pompei P. Antidepressant-induced hyponatraemia in the aged: avoidance and management strategies. Drags Aging. 1996; 8: 430-435. (Pubitemid 126444193)
21. Egger C, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C. A case of recurrent hyponatremia induced by venlafaxine. J Clin Psychopharmacol. 2006; 26: 439. (Pubitemid 44187655)
22. Gupta AK, Saravay SM. Venlafaxine-induced hyponatremia. J Clin Psychopharmacol. 1997; 17: 223-225.
23. You JI, Choi YM. A case report of hyponatremia associated with venlafaxine HCL in an elderly patient. Korean J Psychopharmacol. 2008; 19: 53-57.
24. Bavbek N, Kargili A, Akcay A, Kaya A. Recurrent hyponatremia associated with citalopram and mirtazapine. Am J Kidney Dis. 2006; 48: 61-62.
25. Cheah CY, Ladhams B, Fegan PG. Mirtazapine associated with profound hyponatremia: two case reports. Am J Geriatr Pharmacother. 2008; 6: 91-95.
26. Ladino M, Guardiola VD, Paniagua M. Mirtazapine-induced hyponatremia in an elderly hospice patient. J Palliat Med. 2006; 9: 258-260.
27. Jagsch C, Marksteiner J, Seiringer E, Windhager E. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion. Pharmacopsychiatry. 2007; 40: 129-131. (Pubitemid 46910386)
28. American Psychiatry Association. Diagnostic and statistical manual of mental disorder. 4th edn. Washington DC: American Psychiatric Press; 1994.
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimated glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470.
30. Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry. 2001; 16: 484-493. (Pubitemid 32492382)
31. WHO expert consultation. Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363: 157-163.
32. Degner D, Grohmann R, Kropp S, Rüther E, Bender S, Engel RR, Schmidt LG. Severe adverse drag reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 2004; 37: 39-45.
33. Siegler EL, Tamres D, Berlin JA, Allen-Taylor L, Strom BL. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995; 155: 953-957.
34. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006; 40: 1618-1622. (Pubitemid 44330206)
35. Strachan J, Shepherd J. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Aust N Z J Psychiatry. 1998; 32: 295-298.
36. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and velafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002; 17: 231-237. (Pubitemid 34232595)
37. Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF 3rd, Pollock BG. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med. 2004; 164: 327-332. (Pubitemid 38176475)
38. Miehle K, Paschke R, Koch CA. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): A case report. Pharmacopsychiatry. 2005; 38: 181-182. (Pubitemid 41059226)
39. Movig KL, Leufkens HG, Lenderink AW, Egberts AC. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol. 2002; 58: 143-148. (Pubitemid 34507799)